<http://www.wikidata.org/entity/statement/Q63063555-88EC6A4F-7B37-4CEA-834B-9B33C54D72DA>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://wikiba.se/ontology#BestRank> .
<http://www.wikidata.org/entity/statement/Q63063555-88EC6A4F-7B37-4CEA-834B-9B33C54D72DA>	<http://wikiba.se/ontology#rank>	<http://wikiba.se/ontology#NormalRank> .
<http://www.wikidata.org/entity/statement/Q63063555-88EC6A4F-7B37-4CEA-834B-9B33C54D72DA>	<http://www.wikidata.org/prop/statement/P1476>	"A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multi-Center, Dose Optimization Study Evaluating the Efficacy and Safety of SPD503 in Combination With Psychostimulants in Children and Adolescents Aged 6-17 Years With a Diagnosis of Attention-Deficit/Hyperactivity Disorder (ADHD)"@en .
<http://www.wikidata.org/entity/statement/Q63063555-88EC6A4F-7B37-4CEA-834B-9B33C54D72DA>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://wikiba.se/ontology#Statement> .